DNMT3B and lymphoma: In terms of survival prediction using different DNMT expressions, previous studies showed that overexpression of DNMT1 or DNMT3b was associated with a poor prognosis in cancers of the lung [15], liver [18], [35], and pancreas [17], lymphoma [13] and other malignancies.